This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Jimro Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Hidetaka Maegawa: Innovator in Anti-Drug Antibody Measurement
Introduction
Hidetaka Maegawa is a notable inventor based in Takasaki, Japan. He has made significant contributions to the field of molecular-targeted therapy through his innovative methods. His work focuses on improving the accuracy and simplicity of measuring anti-drug antibodies in patients.
Latest Patents
Hidetaka Maegawa holds a patent for a method for measuring anti-drug antibodies (ADAs). This method provides a simpler and more accurate way to assess the presence of ADAs in patients undergoing molecular-targeted therapy. His invention is crucial for enhancing patient care and treatment efficacy.
Career Highlights
Maegawa is associated with Jimro Co., Ltd., where he continues to develop and refine his innovative approaches. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
He has collaborated with notable colleagues, including Nobuhito Kashiwagi and Fumio Saitoh. These partnerships have fostered a collaborative environment that encourages innovation and progress in their shared field of expertise.
Conclusion
Hidetaka Maegawa's contributions to the measurement of anti-drug antibodies represent a significant advancement in medical technology. His work not only enhances the accuracy of patient assessments but also underscores the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile